abagovomab 38
abciximab 33
abituzumab 22
abrilumab 19
actoxumab 18
adalimumab 21
aducanumab 15
afasevikumab 20
alacizumab_pegol 15
alemtuzumab 26
alirocumab 26
amatuximab 43
andecaliximab 24
anifrolumab 22
anrukinzumab 23
aprutumab 22
aprutumab_ixadotin 22
arcitumomab 27
ascrinvacumab 7
atezolizumab 16
atinumab 17
avelumab 15
basiliximab 36
bavituximab 40
begelomab 32
benralizumab 28
bevacizumab_beta 24
bezlotoxumab 18
bimagrumab 15
bleselumab 19
blinatumomab 38
blosozumab 31
bococizumab 19
brazikumab 18
brentuximab_vedotin 37
briakinumab 20
brodalumab 14
brolucizumab 29
brontictuzumab 27
burosumab 18
cabiralizumab 27
camrelizumab 16
canakinumab 28
cantuzumab_ravtansin 47
carlumab 16
carotuximab 31
cergutuzumab_amunaleukin2 28
cergutuzumab_amunaleukin 28
certolizumab_pegol 25
cetiximab 48
citatuzumab_bogatox 27
cixutumumab 31
clivatuzumab_tetraxetan 24
codrituzumab 32
conatumumab 14
concizumab 33
crenezumab 22
crizanlizumab 26
crotedumab 23
dacetuzumab 22
daclizumab 17
dalotuzumab 39
dapirolizumab_pegol 26
daratumumab 14
dectrekumab 11
demcizumab 29
denosumab 11
depatuxizumab 24
depatuxizumab_mafodotin 24
dezamizumab 21
dinutuximab 39
diridavumab 31
domagrozumab 18
drozitumab 22
duligotuzumab 21
durvalumab 12
dusigitumab 23
efalizumab 33
efungumab 33
eldelumab 17
elezanumab 22
elgemtumab 13
elotuzumab 18
emactuzumab 19
emapalumab 25
emibetuzumab 21
enavatuzumab 25
enfortumab_vedotin 14
enoblituzumab 20
enokizumab 26
enoticumab 20
ensituximab 37
eptinezumab 19
erenumab 27
etaracizumab 18
etrolizumab 22
evinacumab 22
evolocumab 21
farletuzumab 15
fasinumab 23
fezakinumab 23
fibatuzumab 17
ficlatuzumab 24
firivumab 34
flanvotumab 19
fletikumab 27
foralumab 16
foravirumab 16
fremanezumab 31
fresolimumab 17
fulranumab 23
futuximab 36
galcanezumab 23
ganitumab 28
gantenerumab 13
gemetuzumab 31
gemtuzumab2 26
gemtuzumab 30
gevokizumab 24
girentuximab 36
glembatumumab 18
glembatumumab_vedotin 18
guselkumab 27
ibalizumab 30
ibritumomab 40
icrucumab 13
idarucizumab 39
ifabotuzumab 17
imalumab 19
imgatuzumab 20
inclacumab 21
indatuximab_ravtansin 38
indusatumab 19
inebilizumab 33
intetumumab 18
iodine_girentuximab 30
ipilimumab 7
iratumumab 14
isatuximab 40
itolizumab 27
ixekizumab 34
labetuzumab_govitecan 27
lambrolizumab 29
lampalizumab 26
lanadelumab 18
landogrozumab 18
laprituximab 28
lebrikizumab 37
lendalizumab 24
lenzilumab 16
lifastuzumab_vedotin 25
ligelizumab 25
lilotomab 42
lirilumab 24
lodelcizumab 20
lokivetmab 28
lorvotuzumab_mertansin 29
lucatumumab 30
lumretuzumab 22
lupartumab 20
lutikizumab 21
margetuximab 39
milatuzumab 42
mirvetuximab 40
mirvetuximab_soravtansin 40
modotuximab 43
mogamulizumab 36
monalizumab 17
motavizumab 34
moxetumomab_pasudotox 33
namilumab 22
naratuximab 29
naratuximab_emtansin 29
narnatumab 20
navicixizumab2 32
navicixizumab 30
navivumab 39
necitumumab 12
nemolizumab 25
nesvacumab 17
nivolumab 15
obiltoxaximab 24
obinutuzumab 39
ocaratuzumab 27
ofatumumab 20
olaratumab 20
olokizumab 26
omalizumab 20
onartuzumab 23
ontuxizumab 30
opicinumab 14
orticumab 16
otelixizumab 39
oxelumab 14
ozanezumab 34
pamrevlumab 13
panobacumab 31
parsatuzumab 25
pasotuxizumab 23
pateclizumab 19
patritumab 21
pembrolizumab 29
perakizumab 23
pidilizumab 20
pinatuzumab_vedotin 19
plozalizumab 37
pogalizumab 23
polatuzumab_vedotin 22
ponezumab 40
prezalumab 16
pritoxaximab 42
quilizumab 23
racotumomab 33
radretumab 15
ralpancizumab 23
ramucirumab 14
ranevetmab 31
ranibizumab 24
refanezumab 29
remtolumab 21
rilotumumab 21
rinucumab 19
risankizumab 35
rituximab 27
rivabazumab 22
robatumumab 20
roledumab 36
romosozumab 21
rontalizumab 19
rosmantuzumab 25
rozanolixizumab 23
sacituzumab 31
sacituzumab_govitecan 31
samalizumab 27
sapelizumab 24
sarilumab 19
secukinumab 17
seribantumab 17
setoxaximab 47
sifalimumab 12
siltuximab 27
simtuzumab 28
sirukumab 15
solanezumab 27
solitomab 34
stamulumab 21
suptavumab 25
suvizumab 23
tabalumab 16
tadocizumab 19
tamtuvetmab 35
tanezumab 22
tarextumab 12
tavolixizumab 18
telisotuzumab 30
teplizumab 21
tesidolumab 23
tezepelumab 27
tigatuzumab 17
tildrakizumab 22
timolumab 16
tisotumab 16
tosatoxumab 42
tositumomab 39
tralokinumab 30
trastuzumab 24
tregalizumab 34
trevogrumab 15
ublituximab 35
urelumab 20
ustekinumab 29
utomilumab 29
vadastuximab 26
vadastuximab_talirin 26
vandortuzumab_vedotin 18
vantictumab 22
vanucizumab2 24
vanucizumab 32
varlilumab 17
vatelizumab 21
vedolizumab 31
veltuzumab 19
vesencumab 13
vorsetuzumab 28
vorsetuzumab_mafodotin 28
vunakizumab 36
xentuzumab 20
zatuximab 43
